Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

CTI BioPharma announces Q4 and FY 2015 earnings

CTI BioPharma Corp. today reported financial results for the fourth quarter and full year ended December 31, 2015.

17 Feb 2016

CTCA hosts second ‘Annual New Treatments in Oncology’ conference

Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) is hosting its second Annual New Treatments in Oncology (ANTO) conference, focused on advances in cancer research, new treatments and patient care.

17 Feb 2016

Apogenix awarded €3 million grant to develop immuno-oncology candidate APG101 as personalized therapy

Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that it has received funding approval in the amount of €3 million from the German Federal Ministry of Education and Research for the so-called CancerMark project.

16 Feb 2016

Clear Guide SCENERGY CT-Ultrasound fusion system receives FDA 510(k) clearance

Clear Guide Medical has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative CT-Ultrasound fusion and image guidance system, the Clear Guide SCENERGY.

16 Feb 2016

UAB research reveals heterogonous population of leukemia stem cells

University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment.

16 Feb 2016

Research findings identify potential genetics-guided precision medicine for leukemia patients

An international research team has determined how inherited gene variations lead to severe drug toxicity that may threaten chances for a cure in children with leukemia. St. Jude Children's Research Hospital scientists led the study, results of which set the stage to expand the use of a patient's genetic make-up to tailor chemotherapy.

16 Feb 2016

Most stage III melanoma patients do not benefit from interferon treatment

Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment with interferon.

15 Feb 2016

NCCN publishes new guidelines with NCCN Evidence Blocks for Breast, Colon, Kidney, and Rectal Cancers

The National Comprehensive Cancer Network has published the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) with NCCN Evidence Blocks™ for Breast, Colon, Kidney, and Rectal Cancers.

15 Feb 2016

New study addresses needs of long-term cancer survivors

A team of researchers from Yale School of Public Health and Yale Cancer Center recently published a study in the Journal of Cancer Survivorship that addresses the needs of cancer survivors who are at least nine years beyond an initial diagnosis.

15 Feb 2016

Neural gene promotes growth and spread of metastatic breast cancer

When breast cancer becomes advanced and spreads to other organs, patient survival is drastically reduced, prompting the need to explore the genes that may cause tumor cells to metastasize.

15 Feb 2016

MGH study reveals effects of obesity on pancreatic and breast cancer

Massachusetts General Hospital investigators may have uncovered a novel mechanism behind the ability of obesity to promote cancer progression. In their report published online in the journal Clinical Cancer Research, the research team describes finding an association between obesity and an overabundance of a factor called PlGF (placental growth factor) and that PlGF's binding to its receptor VEGFR-1, which is expressed on immune cells within tumors, promotes tumor progression.

12 Feb 2016

CNIO researchers reveal how combination of dasatinib and demcizumab reduces lung adenocarcinomas

Lung cancer is one of the most prevalent types of cancer, with more than 20,000 new cases diagnosed each year in Spain. Lung adenocarcinomas carrying oncogenic KRAS, the engine driving these tumours in 30% of cases, constitute the most aggressive sub-type because, unlike other types of lung cancer, there are no targeted therapies beyond the standard cisplatin-based treatment.

12 Feb 2016

ASTRO encourages policymakers to increase financial support for cancer research in FY 2017 Budget

The American Society for Radiation Oncology commends the proposed investment in cancer-related research announced in the Fiscal Year 2017 Budget released yesterday by the White House.

12 Feb 2016

ASTRO's new research journal 'Advances in Radiation Oncology' closes first issue

Advances in Radiation Oncology, ASTRO's new original research journal, has closed its first issue with research including a phase II clinical trial in prostate cancer, a prospective trial in quality of life for breast cancer patients receiving radiotherapy and several clinical and medical physics reports on the use of stereotactic body radiotherapy.

12 Feb 2016

Novel test could help get best treatment for advanced bowel cancer patients

A NEW test could help patients with advanced bowel cancer get the best treatment for their disease, according to a Cancer Research UK clinical trial published today (Thursday) in JAMA Oncology.

11 Feb 2016

David Calligaris wins ABC Best Paper Award

David Calligaris is the winner of this year's ABC Best Paper Award, presented by the Springer journal Analytical and Bioanalytical Chemistry. In a paper published in ABC, lead author Calligaris and his colleagues describe a novel system using mass spectrometry as an intraoperative tool. Their method opens new possibilities to detect additional tumour markers which are useful in diagnosing brain and breast tumours during surgery.

11 Feb 2016

West Cancer Center introduces promising new treatment method for brain cancer patients

Brain Cancer patients in the Mid-South now have a promising new treatment method at West Cancer Center. Optune™, a portable device using low intensity electric fields to inhibit cancer cell replication causing death of cancer cells, is the first FDA-approved therapy in more than a decade to show a significant extension in overall survival rates for newly diagnosed adult Glioblastoma Multiforme (GBM) patients.

11 Feb 2016

Oncology News and Research

Further Reading

CTI BioPharma announces Q4 and FY 2015 earnings

CTCA hosts second ‘Annual New Treatments in Oncology’ conference

Apogenix awarded €3 million grant to develop immuno-oncology candidate APG101 as personalized therapy

Clear Guide SCENERGY CT-Ultrasound fusion system receives FDA 510(k) clearance

UAB research reveals heterogonous population of leukemia stem cells

Research findings identify potential genetics-guided precision medicine for leukemia patients

Most stage III melanoma patients do not benefit from interferon treatment

NCCN publishes new guidelines with NCCN Evidence Blocks for Breast, Colon, Kidney, and Rectal Cancers

New study addresses needs of long-term cancer survivors

Neural gene promotes growth and spread of metastatic breast cancer

MGH study reveals effects of obesity on pancreatic and breast cancer

CNIO researchers reveal how combination of dasatinib and demcizumab reduces lung adenocarcinomas

ASTRO encourages policymakers to increase financial support for cancer research in FY 2017 Budget

ASTRO's new research journal 'Advances in Radiation Oncology' closes first issue

Novel test could help get best treatment for advanced bowel cancer patients

David Calligaris wins ABC Best Paper Award

West Cancer Center introduces promising new treatment method for brain cancer patients

Study looks at post-treatment resources for prostate cancer patients transitioning to survivorship

Vanderbilt physicians examine risk factors for cardiovascular disease in prostate cancer survivors

Researchers reveal inherited genetic mutations associated with ovarian cancer risk

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News